Mathew Wallis,Simon D Bodek,Jacob Munro,Haloom Rafehi,Mark F Bennett,Zimeng Ye,Amy Schneider,Fiona Gardiner,Giulia Valente,Emma Murdoch,Eloise Uebergang,Jacquie Hunter,Chloe Stutterd,Aamira Huq,Lucinda Salmon,Ingrid Scheffer,Dhamidhu Eratne,Stephen Meyn,Chun Y Fong,Tom John,Saul Mullen,Susan M White,Natasha J Brown,George McGillivray,Jesse Chen,Chris Richmond,Andrew Hughes,Emma Krzesinski,Andrew Fennell,Brian Chambers,Renee Santoreneos,Anna Le Fevre,Michael S Hildebrand,Melanie Bahlo,John Christodoulou,Martin Delatycki,Samuel F Berkovic

Abstract:Background: Significant recent efforts have facilitated increased access to clinical genetics assessment and genomic sequencing for children with rare diseases in many centres, but there remains a service gap for adults. The Austin Health Adult Undiagnosed Disease Program (AHA-UDP) was designed to complement existing UDP programs that focus on paediatric rare diseases and address an area of unmet diagnostic need for adults with undiagnosed rare conditions in Victoria, Australia. It was conducted at a large Victorian hospital to demonstrate the benefits of bringing genomic techniques currently used predominantly in a research setting into hospital clinical practice, and identify the benefits of enrolling adults with undiagnosed rare diseases into a UDP program. The main objectives were to identify the causal mutation for a variety of diseases of individuals and families enrolled, and to discover novel disease genes. Methods: Unsolved patients in whom standard genomic diagnostic techniques such as targeted gene panel, exome-wide next generation sequencing, and/or chromosomal microarray, had already been performed were recruited. Genome sequencing and enhanced genomic analysis from the research setting were applied to aid novel gene discovery. Results: In total, 16/50 (32%) families/cases were solved. One or more candidate variants of uncertain significance were detected in 18/50 (36%) families. No candidate variants were identified in 16/50 (32%) families. Two novel disease genes (TOP3B, PRKACB) and two novel genotype-phenotype correlations (NARS, and KMT2C genes) were identified. Three out of eight patients with suspected mosaic tuberous sclerosis complex had their diagnosis confirmed which provided reproductive options for two patients. The utility of confirming diagnoses for patients with mosaic conditions (using high read depth sequencing and ddPCR) was not specifically envisaged at the onset of the project, but the flexibility to offer recruitment and analyses on an as-needed basis proved to be a strength of the AHA-UDP. Conclusion: AHA-UDP demonstrates the utility of a UDP approach applying genome sequencing approaches in diagnosing adults with rare diseases who have had uninformative conventional genetic analysis, informing clinical management, recurrence risk, and recommendations for relatives.

Experience of the first adult-focussed undiagnosed disease program in Australia (AHA-UDP): solving rare and puzzling genetic disorders is ageless

Integrated multi-omics for rapid rare disease diagnosis on a national scale

Accelerating rare disease detection: an experience of multidisciplinary team model in undiagnosed diseases program in a children's hospital

Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)

Implementing genomic medicine in clinical practice for adults with undiagnosed rare diseases

Neuromuscular disease genetics in underrepresented populations: increasing data diversity

Genomic multidisciplinary teams: A model for navigating genetic mainstreaming and precision medicine

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Joint, multifaceted genomic analysis enables diagnosis of diverse, ultra-rare monogenic presentations

A targeted gene panel illuminates pathogenesis in young people with unexplained kidney failure

Advancing diagnosis and management of liver disease in adults through exome sequencing

Unravelling undiagnosed rare disease cases by HiFi long-read genome sequencing

Undiagnosed Disease Network collaborative approach in diagnosing rare disease in a patient with a mosaic CACNA1D variant

Genomic Testing in Patients with Kidney Failure of an Unknown Cause: A National Australian Study

Unveiling the hidden: revisiting the potential of old genetic data for rare disease research

Rare disease genomic testing in the UK and Ireland: promoting timely and equitable access

Closing the gap: Solving complex medically relevant genes at scale

Enhanced utility of family-centered diagnostic exome sequencing with inheritance model–based analysis: results from 500 unselected families with undiagnosed genetic conditions

An integrated clinical approach to children at genetic risk for neurodevelopmental and psychiatric conditions: interdisciplinary collaboration and research infrastructure

The Eight and a Half Year Journey of Undiagnosed AD: Gene Sequencing and Funding of Advanced Genetic Testing Has Led to Hope and New Beginnings

Precision medicine integrating whole-genome sequencing, comprehensive metabolomics, and advanced imaging